DocMorris Stock

DocMorris EBIT

The EBIT of DocMorris (DOCM.SW) as of Jul 29, 2026 is -84.29 M CHF. In the previous year, EBIT was -104.22 M CHF — a change of -19.13% (higher).

EBIT

-84.29 MCHF

YoY

-19.13%

Last updated:

In 2026, DocMorris's EBIT was -84.29 M CHF, a -19.13% increase from the -104.22 M CHF EBIT recorded in the previous year.

The DocMorris EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M CHF)
Date
EBIT (M CHF)
Jan 1, 2023
-75.83 base
Jan 1, 2024
-104.22 base
Jan 1, 2025
-84.29 base
Jan 1, 2026 (e)
-132.62 base
Jan 1, 2027 (e)
-145.46 base
Jan 1, 2028 (e)
-159.52 base
Jan 1, 2029 (e)
-183.53 base
Jan 1, 2030 (e)
-204.54 base
YEAREBIT (M CHF)
2030 est -204.54
2029 est -183.53
2028 est -159.52
2027 est -145.46
2026 est -132.62
2025 -84.29
2024 -104.22
2023 -75.83
2022 40.49
2021 -200.70
2020 -114.17
2019 -44.27
2018 -36.66
2017 -33.92
2016 -7.09
2015 8.44
2014 8.21
2013 -11.26
2012 7.52
2011 5.19
2010 7.43
Access this data via the Eulerpool API

DocMorris Revenue

DocMorris Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
969.46 M CHF
-75.83 M CHF
82.28 M CHF
Jan 1, 2024
1.02 B CHF
-104.22 M CHF
-97.25 M CHF
Jan 1, 2025
1.12 B CHF
-84.29 M CHF
-134.40 M CHF
Jan 1, 2026 (e)
1.24 B CHF
-132.62 M CHF
-89.28 M CHF
Jan 1, 2027 (e)
1.36 B CHF
-145.46 M CHF
-49.18 M CHF
Jan 1, 2028 (e)
1.49 B CHF
-159.52 M CHF
-18.38 M CHF
Jan 1, 2029 (e)
1.72 B CHF
-183.53 M CHF
8.33 M CHF
Jan 1, 2030 (e)
1.92 B CHF
-204.54 M CHF
39.95 M CHF

DocMorris Margins

DocMorris stock margins

The DocMorris margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DocMorris. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DocMorris.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
20.98 %
-7.82 %
8.49 %
Jan 1, 2024
21.29 %
-10.25 %
-9.56 %
Jan 1, 2025
9.40 %
-7.50 %
-11.95 %
Jan 1, 2026 (e)
9.40 %
-10.68 %
-7.19 %
Jan 1, 2027 (e)
9.40 %
-10.68 %
-3.61 %
Jan 1, 2028 (e)
9.40 %
-10.68 %
-1.23 %
Jan 1, 2029 (e)
9.40 %
-10.68 %
0.48 %
Jan 1, 2030 (e)
9.40 %
-10.68 %
2.09 %

DocMorris Stock analysis

What does DocMorris do? The Zur Rose Group AG is a Swiss company that specializes in online trading of medications and health products. The company was founded in 1993 in Steckborn and initially focused on the mail order of homeopathic medicines. In 1997, the online shop www.zurrose.de was opened and the company began to expand its distribution to non-homeopathic medicines. The business model of the Zur Rose Group AG is based on a three-pillar model, encompassing e-commerce, wholesale, and healthcare. In the e-commerce sector, the company operates online pharmacies in various countries including Germany, France, Austria, the Netherlands, and Switzerland. In the wholesale sector, the company supplies pharmacies and hospitals with medicines and medical products. In the healthcare sector, the company offers various services in healthcare, from the production of medicines to the processing of prescriptions. The Zur Rose Group AG offers a wide range of products and services including prescription and over-the-counter medications, natural remedies, cosmetic products, dietary supplements, and medical devices. The company aims to provide its customers with a comprehensive selection of high-quality products and works closely with its suppliers to ensure that all products meet the highest quality standards. In the e-commerce sector, the company operates various online pharmacies, including Zur Rose Apotheke in Germany, Zur Rose Apotheke in Austria, and Doctipharma in France. These online pharmacies offer a wide range of medications and health products that can be ordered online and conveniently delivered to customers' homes. The online pharmacies are open 24/7, allowing customers to quickly and easily order their needed medications. In the wholesale sector, the company offers a wide range of pharmaceutical products and medical devices to pharmacies and hospitals. The company works closely with its suppliers to ensure that all products meet the highest quality standards. Additionally, the company also provides a fast and reliable delivery service to ensure that its customers are always provided with the needed medications and medical products. In the healthcare sector, the company offers various services in healthcare, including digitalization solutions for pharmacies, manufacturing of medications, and processing of prescriptions. The company works closely with its customers to offer tailored solutions that meet their individual requirements. Over the years, the Zur Rose Group AG has become a leading provider in the online trading of medications and health products. The company has distinguished itself through its wide product range, fast and reliable delivery service, and excellent customer service. Additionally, the company has also invested in the development of new technologies to ensure that it can always offer its customers the best products and services. Overall, the Zur Rose Group AG is an innovative company built on a long history in healthcare. The company strives to offer its customers a wide range of high-quality products and services and has established itself as a leading provider in the online trading of medications and health products. DocMorris is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing DocMorris's EBIT

DocMorris's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of DocMorris's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

DocMorris's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in DocMorris’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about DocMorris stock

EBIT of DocMorris is -84.29 M CHF in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — DocMorris

All Key Metrics — DocMorris